References
1. Jennette JC FR, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013; 65 : 1–11.
2. McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Schonlein purpura. European journal of pediatrics 2010; 169 : 643-50.
3. Aktas B TP, Kurt OK, Ensari A, Demirer T. Severe Henoch-Schönlein Purpura Induced by Cytarabine. Ann Pharmacother 2009 43 : 792–3.
4. Watanabe T. Henoch-Schonlein purpura following influenza vaccinations during the pandemic of influenza A (H1N1). Pediatric nephrology 2011; 26 : 795-8.
5. Jariwala S VN, Shliozberg J. Henoch-Schonlein purpura after hepatitis A vaccination. Ann Allergy Asthma Immunol 2011; 107 : 180–1.
6. Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schonlein Purpura: A Literature Review. Acta dermato-venereologica 2017; 97 : 1160-6.
7. Heineke M. H, Ballering, A.V, Jamin A, Ben Mkaddem, S, Monteiro, R. C, Van Egmond M. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura). Autoimmunity reviews 2017; 16 : 1246-53.
8. Kurotobi S, Kawakami N, Honda A, Matsuoka T, Hara T, Nagai T, et al. Impaired vascular endothelium-dependent relaxation in Henoch-Schonlein purpura. Pediatric nephrology 2004; 19 : 138-43.
9. Dursun I, Dusunsel R, Poyrazoglu HM, Gunduz Z, Patiroglu T, Ulger H, et al. Circulating endothelial microparticles in children with Henoch-Schonlein purpura; preliminary results. Rheumatology international 2011; 31 : 1595-600.
10. Van der Poll T, Parker RI. Platelet Activation and Endothelial Cell Dysfunction. Critical care clinics 2020; 36 : 233-53.
11. Culic S JR. Purpura anaphylactoides (Schöenlein-Henoch) in childhood as the consequence of immune vasculitis and immune thrombocytopathia. Thromb Haemost Abstracts XVI Congress of the International Society on Thrombosis and Haemostasis Florence, Italy (Suppl)June 1997: p. 272.
12. Edekmann CM Jr BJ, Meadow SR, Spitter A, Travis LB. Schonlein-Henoch Syndrome. In: Pediatric Kidney Disease, (2nd edition), Little, Brown and Company 1992: 1525-33.
13. Culic S JR, Metlicic V, Paukovic-Sekulic B, Resic B, Culic V, Kuljis D, Primorac D. Platelet function analysis in children with Schonlein–Henoch syndrome. Arch Med Res 2001; 32 : 268–72.
14. Mishkova R. KK, Petrova E. Hemostatic disorders in patients with Schoenlein–Henoch syndrome, in Russian. Klin Med (Mosk) 1990; 68 : 47-9.
15. Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PRES endorsed consensus criteria for the classification of childhood vasculitides. . Ann Rheum Dis 2006; 65 : 936-41.
16. Shi X, Li WC, Mo LJ, Li XH, Luo YZ, Qin LQ, et al. Altered mean platelet volume in children with Henoch-Schonlein purpura and its association with disease activity. Annals of clinical biochemistry 2018; 55 : 368-72.
17. Boros G GL, Sámsik J, Nagy J, Hámori A, Deák G . Blood coagulation abnormalities in the Schönlein-Henoch syndrome in adults. Acta Med Acad Sci Hung 1979;36 : 151-66.